diabetic foot ulcer. Peripheral angiopathy in diseases classified elsewhere
Conditions
Interventions
Intervention 1: Control group: Just routine treatment. Intervention 2: Intervention group: Routine treatment plus oral N-acetyl cysteine 1200 mg daily for 2 weeks.
Treatment - Drugs
Intervention group: Routine treatment plus oral N-acetyl cysteine 1200 mg daily for 2 weeks.
Sponsors
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age of 18 to 65 years; diabetic foot ulcer. Exclusion criteria: pregnancy; breastfeeding; abscess; stomatitis; smoking.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound healing. Timepoint: 2 weeks after treatment. Method of measurement: through physical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total antioxidant capacity. Timepoint: 2 weeks after treatment. Method of measurement: through laboratory test.;Lipid peroxidase. Timepoint: 2 weeks after treatment. Method of measurement: through laboratory test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoheil Madadi
School of Pharmacy
Outcome results
None listed